An observational study in Hip Fracture, Proximal Femur Fracture and Frailty, sponsored by Trakya University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-03-31.
Sponsored by Trakya University · Observational
Hip fractures are serious injuries that occur mostly in older adults. Many people experience health problems or may die in the months after surgery. Doctors try to identify patients who have a higher risk of poor outcomes as early as possible.
Doctors often use the Nottingham Hip Fracture Score (NHFS) to estimate the risk of death after hip fracture surgery. This score uses information such as age and other health conditions. However, it does not fully reflect how physically vulnerable a person may be.
Another important concept is frailty. Frailty describes how strong or weak a person's overall health and physical reserve are. In this study, frailty will be measured using the Clinical Frailty Scale (CFS). This scale evaluates a person's level of independence and physical function before the fracture.
The purpose of this study is to determine whether measuring frailty can improve the prediction of death after hip fracture surgery.
Older adults with hip fractures who undergo surgery will be invited to participate in the study. Researchers plan to include about 200 participants or all eligible patients enrolled within one year, whichever occurs first. Health information that is already collected during routine hospital care will be recorded. Frailty will be assessed when participants are admitted to the hospital.
Participants will be followed for 30 days and 90 days after surgery to determine survival status. Researchers will review hospital records and may contact participants or their relatives by phone if needed.
The results of this study may help doctors better identify patients at higher risk and improve care planning after hip fracture surgery.
Hip fractures in older adults are associated with substantial morbidity, loss of independence, and high early mortality. Identifying patients at increased risk of poor outcomes is therefore an important part of perioperative care and treatment planning. Several clinical tools have been developed to estimate short-term mortality following hip fracture surgery. Among these, the Nottingham Hip Fracture Score (NHFS) is widely used and has been validated in multiple patient cohorts.
The NHFS is calculated using routinely available clinical variables such as age, comorbid conditions, and laboratory values. Although this score performs reasonably well in predicting short-term mortality, it mainly reflects comorbidity burden and demographic factors. It does not directly measure the patient's physiological reserve or overall vulnerability to stress.
Frailty has gained increasing attention as an important determinant of surgical outcomes in older adults. Frailty represents a state of reduced physiological reserve that limits the ability to recover from acute health events such as trauma or surgery. The Clinical Frailty Scale (CFS) is a practical bedside tool that classifies frailty based on functional status and the level of independence prior to illness or injury. Because it can be applied quickly in routine clinical settings, it has been used in various studies evaluating outcomes in geriatric populations.
Despite growing interest in frailty assessment, its added value when combined with established hip fracture risk scores remains uncertain. In particular, there is limited prospective evidence examining whether frailty assessment improves mortality prediction beyond existing tools such as the NHFS.
This prospective observational cohort study will collect standardized clinical data from older adults undergoing surgical treatment for proximal femoral fractures. Frailty will be assessed at hospital admission using the Clinical Frailty Scale based on the participant's functional status before the fracture. The Nottingham Hip Fracture Score will be calculated from routinely recorded clinical variables.
The analysis will examine the relationship between NHFS, frailty status, and short-term mortality following surgery. Predictive models including NHFS alone will be compared with models that incorporate both NHFS and frailty status in order to determine whether frailty provides additional prognostic information.
Understanding whether frailty assessment improves risk prediction may help clinicians identify vulnerable patients earlier and support more individualized perioperative management in older adults with hip fractures.
36 studies on the registry are indexed under Proximal Femoral Fractures; 6 are open to participants now.
This study's planned enrollment of 200 is above the median of 140 across 13 observational studies indexed under Proximal Femoral Fractures.
Browse Proximal Femoral Fractures studies →Trakya University is the lead sponsor of 155 studies on the registry; 15 are open to participants now.
Compared within Proximal Femoral Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hip Fractures. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Older adults admitted with proximal femoral fractures who undergo surgical treatment at Trakya University Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Older adults aged 60 years or older who undergo surgical treatment for proximal femoral fractures. Frailty will be assessed using the Clinical Frailty Scale and mortality outcomes will be evaluated at 30 and 90 days after surgery.
Other: No Intervention: Observational Cohort
no intervention
90 Day All Cause Mortality
All cause mortality occurring within 90 days after hip fracture surgery.
Time frame: 90 days after surgery
30 Day All Cause Mortality
All cause mortality occurring within 30 days after hip fracture surgery.
Time frame: 30 days after surgery
Postoperative complications
Time frame: 90 days after surgery
Length of hospital stay
Time frame: From hospital admission to hospital discharge (up to 30 days)
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.